Filter by: patients
Home > Community Treatment Reports and Side Effects > Cordyceps Treatment Report
What is Cordyceps?

Cordyceps includes fungus that grows on caterpillar larvae. Both are contained in the product and consumed. Cordyceps is used for a wide range of conditions including fatigue, sexual dysfunction, coughs, and as an adaptogen or immune stimulant.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
General health 1 0
Energy level 1 0
Fatigue 1 0
Support immune health 1 1 Efficacy_moderate
Fibromyalgia 1 1 Efficacy_major
Chronic Fatigue Syndrome 1 0

See all 4 patients currently taking Cordyceps

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 2

Reported Dosages

  1 other daily 200 mg daily 1,000 mg daily 1,200 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Cordyceps (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1   Other: 50%
Course of treatment ended 1   Course of treatment ended: 50%

See all 2 patients who’ve stopped taking Cordyceps

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Cordyceps

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Cordyceps

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Cordyceps

Always
 0 0%
Usually
 1 50%
Sometimes
 0 0%
Never
 1 50%

Burden

Difficulty being on treatment

Burden of Cordyceps

Very
 0 0%
Somewhat
 1 50%
A little
 0 0%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Cordyceps

$200+
 0 0%
$100-199
 0 0%
$50-99
 2 100%
$25-49
 0 0%
< $25
 0 0%

Report created on May 28, 2012.